发明申请
US20100267690A1 TRICYCLIC GUANIDINE DERIVATIVES AS SODIUM-PROTON EXCHANGE INHIBITORS
失效
三聚氰胺衍生物作为钠基交换剂抑制剂
- 专利标题: TRICYCLIC GUANIDINE DERIVATIVES AS SODIUM-PROTON EXCHANGE INHIBITORS
- 专利标题(中): 三聚氰胺衍生物作为钠基交换剂抑制剂
-
申请号: US12827277申请日: 2010-06-30
-
公开(公告)号: US20100267690A1公开(公告)日: 2010-10-21
- 发明人: Bansi LAL , Swati Bal-Tembe , Usha Ghosh , Arun Kumar Jain , Tulsidas More , Anil Ghate , Jacqueline Trivedi , Sapna Parikh
- 申请人: Bansi LAL , Swati Bal-Tembe , Usha Ghosh , Arun Kumar Jain , Tulsidas More , Anil Ghate , Jacqueline Trivedi , Sapna Parikh
- 申请人地址: IN Mumbai
- 专利权人: Piramal Life Sciences Limited
- 当前专利权人: Piramal Life Sciences Limited
- 当前专利权人地址: IN Mumbai
- 优先权: IN1225/MUM/2004 20041110
- 主分类号: A61K31/554
- IPC分类号: A61K31/554 ; A61K31/155 ; A61K31/445 ; A61K31/40 ; A61K31/27 ; A61K31/255 ; A61K31/4965 ; A61K31/5375 ; A61K31/4174 ; A61K31/34 ; A61K31/381 ; A61K31/497 ; A61K31/5377 ; A61K31/39 ; A61P9/10 ; A61P3/00 ; A61P25/00
摘要:
Guanidine derivatives having a condensed tricyclic ring of formula 1: are disclosed, wherein U is C(O), CRaRb, O, NRa or S(O)m; V is CRaRb or NRa; W is S(O)m; wherein Ra is H, alkyl, cycloalkyl, alkenyl or aralkyl; Rb is H, alkyl, OH, ORa or OCORa, and m is the integer 0, 1 or 2; R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein with the proviso that at least one of R1, R2, R3, R4, R5, R6, R7 or R8 is guanidino or guanidino carbonyl. These derivatives are sodium-proton exchange inhibitors and are useful as medicaments for the treatment of, for example, organ disorders associated with ischemia and reperfusion, cardiac arrhythmia, cardiac hypertrophy, hypertension, cell proliferative disorders and diabetes.
公开/授权文献
信息查询